COM:PROQR
ProQR Therapeutics
- Stock
Last Close
3.61
22/11 21:00
Market Cap
295.62M
Beta: -
Volume Today
390.09K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -3.25M - | -12.13M 272.79% | -20.83M 71.77% | -39.12M 87.79% | -43.52M 11.26% | -37.09M 14.79% | -56.75M 53.01% | -46.61M 17.86% | -61.68M 32.32% | -64.89M 5.21% | -27.54M 57.56% | |
depreciation and amortization | 24K - | 126K 425% | 480K 280.95% | 1.25M 159.38% | 1.06M 14.46% | 992K 6.85% | 2.05M 106.85% | 2.35M 14.77% | 2.33M 1.10% | 2.52M 8.24% | 2.46M 2.36% | |
deferred income tax | 13K - | 142K 992.31% | 441K 210.56% | 236K 46.49% | 145K 38.56% | 102K 29.66% | 235K 130.39% | 124K 47.23% | 117K 5.65% | 96K 17.95% | -78K 181.25% | |
stock based compensation | 41K - | 646K 1,475.61% | 1.21M 87.62% | 2.45M 102.48% | 4.02M 63.98% | 3.22M 19.88% | 9.11M 182.51% | 7.84M 13.94% | 6.22M 20.69% | 2.87M 53.84% | 3.11M 8.26% | |
change in working capital | 829K - | 1.09M 31.48% | 637K 41.56% | 1.43M 124.96% | 164K 88.56% | 1.29M 689.02% | 1.78M 37.79% | -5.01M 381.04% | 25.00M 598.80% | -5.43M 121.74% | 47.95M 982.45% | |
accounts receivables | ||||||||||||
inventory | ||||||||||||
accounts payables | ||||||||||||
other working capital | ||||||||||||
other non cash items | 14K - | -4.33M 31,057.14% | -6.17M 42.39% | -470K 92.38% | 3.17M 775.53% | 792K 75.06% | -402K 150.76% | -5.75M 1,330.85% | 2.01M 134.96% | -3.67M 282.45% | -4.79M 30.64% | |
net cash provided by operating activities | -2.33M - | -14.46M 519.94% | -24.23M 67.61% | -34.22M 41.22% | -34.95M 2.13% | -30.68M 12.21% | -43.97M 43.31% | -47.06M 7.03% | -26.01M 44.73% | -68.51M 163.37% | 21.11M 130.81% | |
investments in property plant and equipment | -137K - | -1.23M 800% | -1.32M 7.38% | -2.54M 91.77% | -121K 95.23% | -312K 157.85% | -580K 85.90% | -924K 59.31% | -484K 47.62% | -708K 46.28% | -3.65M 414.93% | |
acquisitions net | 61.35K - | 5.89K 90.40% | 58.77K 897.46% | |||||||||
purchases of investments | ||||||||||||
sales maturities of investments | ||||||||||||
other investing activites | -2.35K - | 108.06 104.59% | 7.78M 7,196,874.80% | |||||||||
net cash used for investing activites | -137K - | -1.23M 800% | -1.32M 7.38% | -2.54M 91.77% | -121K 95.23% | -312K 157.85% | -580K 85.90% | -924K 59.31% | -425K 54.00% | -702K 65.18% | 4.19M 696.91% | |
debt repayment | -34K - | -34K 0% | -15K 55.88% | -1.26M - | -605K 52.02% | -820K 35.54% | -45.05M 5,393.41% | -987.33K 97.81% | ||||
common stock issued | 3.02M - | 118.25M 3,811.68% | 25.68M - | 86.38M 236.31% | 48.55M 43.79% | 684.79K 98.59% | 108.48M 15,740.80% | 14.12M 86.98% | 346.74K 97.54% | |||
common stock repurchased | ||||||||||||
dividends paid | ||||||||||||
other financing activites | 3.33M - | 1.67M 49.88% | 1.65M 0.78% | 372K 77.51% | 955K 156.72% | 2.27M 137.28% | 2.91M 28.42% | 14.42M 395.54% | 29.18M 102.32% | 34K 99.88% | -1.59M 4,769.93% | |
net cash used provided by financing activities | 6.35M - | 119.88M 1,788.22% | 1.62M 98.65% | 357K 77.96% | 26.64M 7,362.18% | 88.65M 232.76% | 50.20M 43.37% | 14.50M 71.11% | 136.83M 843.67% | -30.89M 122.58% | -2.23M 92.79% | |
effect of forex changes on cash | 4.41M - | 6.07M 37.40% | 738K 87.83% | -2.67M 461.65% | -171K 93.59% | 721K 521.64% | -2.63M 464.49% | 1.29M 149.12% | 7.35M 469.40% | 599K 91.85% | ||
net change in cash | 3.88M - | 108.61M 2,699.15% | -17.87M 116.45% | -35.66M 99.57% | -11.10M 68.87% | 57.48M 617.80% | 6.37M 88.92% | -36.11M 666.91% | 111.69M 409.28% | -92.75M 183.04% | 24.51M 126.43% | |
cash at beginning of period | 249K - | 4.13M 1,558.23% | 112.74M 2,630.35% | 94.86M 15.85% | 59.20M 37.60% | 48.10M 18.75% | 105.58M 119.51% | 111.95M 6.03% | 75.84M 32.26% | 187.52M 147.27% | 94.51M 49.60% | |
cash at end of period | 4.13M - | 112.74M 2,630.35% | 94.86M 15.85% | 59.20M 37.60% | 48.10M 18.75% | 105.58M 119.51% | 111.95M 6.03% | 75.84M 32.26% | 187.52M 147.27% | 94.78M 49.46% | 119.02M 25.58% | |
operating cash flow | -2.33M - | -14.46M 519.94% | -24.23M 67.61% | -34.22M 41.22% | -34.95M 2.13% | -30.68M 12.21% | -43.97M 43.31% | -47.06M 7.03% | -26.01M 44.73% | -68.51M 163.37% | 21.11M 130.81% | |
capital expenditure | -137K - | -1.23M 800% | -1.32M 7.38% | -2.54M 91.77% | -121K 95.23% | -312K 157.85% | -580K 85.90% | -924K 59.31% | -484K 47.62% | -708K 46.28% | -3.65M 414.93% | |
free cash flow | -2.47M - | -15.69M 535.48% | -25.56M 62.88% | -36.76M 43.84% | -35.07M 4.59% | -30.99M 11.63% | -44.55M 43.74% | -47.98M 7.71% | -26.50M 44.78% | -69.22M 161.23% | 17.46M 125.23% |
All numbers in (except ratios and percentages)